Reference Source

Mcneil Products · 66-41 · UNITED KINGDOM

For Mcneil Products, import alert is 66-41; country is UNITED KINGDOM; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is Nicorette Nasal Spray; product code is 66 B - - 44 Nicotine Delivery System; date published is 11/03/2014; address is Maidenhead , Berkshireberkshire, UNITED KINGDOM, verified against its source on 2026-10-01.

Firm
Mcneil Products verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
UNITED KINGDOM verified
Address
Maidenhead , Berkshireberkshire, UNITED KINGDOM verified
Date published
11/03/2014 verified
Product code
66 B - - 44 Nicotine Delivery System verified
Product
Nicorette Nasal Spray verified
FDA notes
The referenced product appears to be an unapproved new drug as the product labeling lists claims such as; 'Nicorette Nasal Spray is for the rapid relief of nicotine withdrawal symptoms as an aid to giving up smoking;' 'To relieve cravings and nicotine withdrawal symptoms;' and 'You are more likely to quit smoking when using this product with help from your pharmacist; doctor; a trained counsellor or a support programme'. verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Mcneil Products Date Published : 11/03/2014 Maidenhead , Berkshireberkshire, UNITED KINGDOM

— accessdata.fda.gov, retrieved 2026-09-15

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Product code, Product and FDA notes

66 B - - 44 Nicotine Delivery System Date Published: 11/03/2014 Desc: Nicorette Nasal Spray Notes: The referenced product appears to be an unapproved new drug as the product labeling lists claims such as; 'Nicorette Nasal Spray is for the rapid relief of nicotine withdrawal symptoms as an aid to giving up smoking;' 'To relieve cravings and nicotine withdrawal symptoms;' and 'You are more likely to quit smoking when using this product with help from your pharmacist; doctor; a trained counsellor or a support programme'.

— all from accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.